Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus. [PDF]
Microbiol Spectr, 2023 Negatu DA, Aragaw WW, Dartois V, Dick T.
europepmc +1 more source
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model. [PDF]
Antimicrob Agents Chemother, 2023 Li SY +7 more
europepmc +1 more source
Improved Radiosynthesis of [<sup>18</sup>F]-Labeled Oxazolidinone Antibiotics for Future Clinical Translation. [PDF]
ACS Infect DisSarhan M +9 more
europepmc +1 more source
In Vitro Activity of Oxazolidinone against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates. [PDF]
Antimicrob Agents Chemother, 2021 Kim DH, Kim SY, Koh WJ, Jhun BW.
europepmc +1 more source
New drugs for the management of tuberculosis. [PDF]
Curr Opin Infect DisCross GB.
europepmc +1 more source
In Vitro Activities of Oxazolidinone Antibiotics Alone and in Combination with C-TEMPO against Methicillin-Resistant Staphylococcus aureus Biofilms. [PDF]
Antibiotics (Basel), 2023 Ndukwe ARN +5 more
europepmc +1 more source
Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies. [PDF]
J Clin Tuberc Other Mycobact DisTimboe K, Jackson JB, Becker GL.
europepmc +1 more source
The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis. [PDF]
Drugs, 2022 Edwards BD, Field SK.
europepmc +1 more source
Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs. [PDF]
Nat CommunChen X +13 more
europepmc +1 more source
Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case Studies. [PDF]
J Med ChemKovar O +7 more
europepmc +1 more source